肝源性糖尿病临床分析

目的：探讨肝源性糖尿病与慢性肝病临床类型的关系。方法：对肝源性糖尿病121例临床资料进行回顾性分析。结果：肝源性糖尿病的发生率在乙型肝炎患者中为10．3％(121／1246)，其中慢性肝炎患者中为7．3％(42／575)，慢性重型肝炎中为5．9％(26／41)；肝硬化中为23．0％(53／230)，与慢性肝炎、慢性重型肝炎相比，差异显著(P＜0．01)。肝源性糖尿病患者中血糖重度升高的比率，肝硬化与慢性肝炎、慢性重型肝炎相比，差异显著(P＜0．01)。通过控制饮食、保肝、抗病毒和/或胰岛素治疗，除2例死亡外，其他患者血糖水平均得到有效控制。结论：糖尿病是慢性肝病的常见并发症，多发生于肝硬化患者，糖尿病轻重与肝损害程度成正比。在控制饮食、保肝、抗病毒和胰岛素治疗后，效果较好。

Clinic analysis of hepatogenic diabetes

Objective:To investigate relationships between hepatogenic diabetes and the clinical types of chronic liver diseases.Methods:Clinical data of 1246 liver diseases and 121 hepatogenic diabetes patients were collected and analyzed .Results:Of 1246 liver diseases patients, 121 (10.3%) were hepatogenic diabetes, of 575 chronic hepatitis patients, 42 (7.3%) were hepatogenic diabetes, of 441 chronic failure hepatitis patients, 26 (5.9%) were hepatogenic diabetes, of 230 liver cirrhosis patients, 53 (23.0%) were hepatogenic diabetes( P < 0.01).Conclusion:Diabetes were common complication of chronic liver disease, the patients of cirrhosis were prone to be resulted in hepatogenic diabetes, the effectiveness of treatment of hepatogenic diabetes patients will be raised by protecting liver function.